SecProbe.io

Stored correspondence activity detail
Intelligence Terminal Search Probe Scores Topics Monthly Activity About

Correspondence Activity Detail

Anebulo Pharmaceuticals, Inc. (ANEB)
Activity window: Oct. 25, 2025 to Oct. 24, 2026

Back View Correspondence Compare Probe Scores Download Probe Score CSV

Export this company’s current score, component values, matched signals, and scoring date as a one-row CSV snapshot.

Probe Score Breakdown

Current total
2.5 / 10
Correspondence-letter component
1.0
AI sentiment component
1.5
Keyword-match component
0.0
Signal-match component
0.0
Notable 8-K modifier
0.0

The total combines correspondence volume, AI sentiment, matched keywords and signals, and a weighted 8-K adjustment, capped at 10.0. This is the 365-day v1 snapshot. Computed: Oct. 24, 2026. Latest filing activity: Jan. 8, 2026. These dates describe different events.

Correspondence Filings
1
Keyword Matches
0
Latest Activity
Jan. 8, 2026
Related 8-Ks
0

Matched Signals

No stored keyword or signal matches were recorded for this activity window.

Filings In This Window

DateFormSentimentUrgencySummaryOpen
Jan. 8, 2026 CORRESP Concern from SEC Moderate Anebulo Pharmaceuticals, Inc. submitted a response to the SEC regarding comments on their Schedule TO-I and Schedule 13E-3 filings. The correspondence addresses concerns about the… Read Filing EDGAR
Dec. 31, 2025 UPLOAD Concern from SEC High The SEC has reviewed Anebulo Pharmaceuticals, Inc.'s recent filings related to a going private transaction and has issued several comments requiring clarification and additional i… Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in this activity window.